Busca
Exibindo 1621 - 1650 de 2726
Faced with the current pandemic scenario, Fiocruz released this Tuesday (March 16), another edition of the Fiocruz COVID-19 Observatory Extraordinary Bulletin. The analysis draws attention to the indicators that point to an extremely critical situation across the country. In the view of the researchers who carry it out, this is the biggest health system collapse in the history of Brazil.
The Bulletin shows that, at the moment, of the 27 federative units, 24 states and the Federal District have occupancy rates for ICU COVID-19 beds for adults in the Brazilian Public Health System (SUS,…
Article
On March 11, one year since the World Health Organization (WHO) declared that the COVID-19 epidemic represented a global pandemic, the new Bulletin of the COVID-19 Observatory Fiocruz highlights that Brazil is among the countries with the worst indicators. The country totals 11,122,429 cases and 268,370 deaths, which corresponds to 9.5% and 10.3% of the global total, respectively, even though the Brazilian population is less than 3% of the world's population.
In a context in which Brazil faces the worst scenario since the pandemic began, researchers at the COVID-19 Fiocruz Observatory,…
Article
The Brazilian Health Regulatory Agency (Anvisa) granted the definitive registration of the COVID-19 Fiocruz vaccine on March 12. Thus, Fiocruz becomes the first holder of a registration of a COVID -19 vaccine produced in the country and adds to its product portfolio the eleventh vaccine to be supplied to the National Immunization Program (PNI). With the registration, the expectation is that Anvisa will authorize the release of the first batches week so that, Fiocruz can deliver to PNI the first one million Covid-19 vaccines produced by the institution.
"Just six months after signing…
Article
A Fundação Oswaldo Cruz (Fiocruz) lançou (5/3) o boletim da pesquisa Monitoramento da saúde, acesso à EPIs de técnicos de enfermagem, agentes de combate às endemias, enfermeiros, médicos e psicólogos, no município do Rio de Janeiro em tempos de Covid-19. O documento foi desenvolvido pela equipe da pesquisa, que conta com doze professoras-pesquisadoras da Escola Politécnica de Saúde Joaquim Venâncio (EPSJV/Fiocruz), em parceria com pesquisadores do Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Icict/Fiocruz), do Núcleo de Saúde do Trabalhador (Nust/Fiocruz…
Article
In an extraordinary edition of its Bulletin, the Covid-19 Fiocruz Observatory publishes an updated of the historical series on the occupation of COVID-19 ICU beds for adults in the Brazilian Health System (SUS, in the Portuguese acronym), with data obtained on Monday (8/3). The analysis presents rates verified since July 17th, 2020, and aims to alert to the critical scenario of the country. Check out the full document (in Portuguese).
According to the Bulletin, of the total of 27 capitals of the country, 25 have occupancy rates of COVID-19 ICU beds for adults equal to or greater than 80%, 15…
Article
Fiocruz president, Nísia Trindade Lima, participated in a World Health Organization (WHO) discussion on how investing in research on Covid-19 treatments can increase cooperation at national and international levels, on March 3. The discussion table, named Towards a Shared Research Agenda, included in the debate on how to identify knowledge gaps and research priorities for COVID-19 treatments, to incentivize cooperation and coordination for the priorities identified.
In her speech, the president mentioned six items for discussion, based on the experience of Fiocruz and of the Evandro…
Article
Many affluent countries, with the necessary technological capabilities and expertise, entered into the production of Covid-19 vaccines or sought the biopharmaceutical companies to block them for themselves through anticipated buying. It is estimated that as early December 2020, 3.8 billion vaccine doses had been guaranteed to these countries by several producers. If one compares that figure with the 3.2 billion doses, that include the 700 million doses from the Covax facility, for the rest of the world one cannot help being struck by the immensity of the inequity. The USA and the UK, for…
Article
In a technical release issued last Thursday (March 3) by the Fiocruz Covid-19 Observatory, researchers warn of the geographical dispersion, in the territory, of “worrying variants” and of their high prevalence in the three Brazilian regions under study (South, South-East and North-East).
The new RT-PCR protocol, developed by Fiocruz Amazônia, was used by Fiocruz diagnostic support units and testing stations to evaluate about one thousand samples from the states of Alagoas, Minas Gerais, Pernambuco, Paraná, Rio de Janeiro, Rio Grande do Sul and Santa Catarina. The protocol…
Article
When the first Portuguese and Spanish ships moored along the coast of the Americas, microorganisms that caused common disease in Europe, but which had never occurred in American soil, disembarked along with the crews. The causer of visceral leishmaniasis, Leishmania infantum is part of a group of microscopic travelers which, despite the huge differences between the Old and the New World, managed to settle here quite well.
More than 500 years later, a study suggests that the evolution of this pathogen in the tropics has followed a surprising trajectory. Leishmaniasis that…
Article
A pioneering study used the genomic sequencing of samples of Mycobacterium tuberculosis to assess the resistance of indigenous peoples to anti-tuberculosis drugs. Published on Scientific Reports, a magazine of the Nature group, the research also revealed a high frequency of polymorphisms associated with resistance to the main drugs used in the treatment. The article, titled Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population, boasts the participation of researchers Paulo Basta and Reinaldo Santos, of the…
Article
An important step to understanding the dynamics of arbovirus transmission, such as dengue fever, zika and chikungunya, is to get to know mosquitoes’ ability to get infected and to transmit the viruses that cause these diseases. This characteristic is technically known as vectorial competence. A study by researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) showed that the Aedes aegypti has low vectorial competence for the zika virus when feeding directly on infected monkeys. The work suggests that virus transmission is much more affected by the high density of the insect in a certain region…
Article
A study of the Oswaldo Cruz Institute (IOC/Fiocruz) was received the Small Grants award of the Royal Society of Tropical Medicine and Hygiene (RSTMH). The research was made by post-doctorate student Viviane de Almeida Bastos, under the supervision of researchers Ana Gisele Ferreira and Richard Hemmi Valente, of the IOC’s Toxicology Laboratory, and investigates natural inhibitors of snake toxins, isolated from South American opossum Didelphis aurita, using the mass spectrometry technique.
“Our intention is to map the regions of the antiphonic proteins involved in the inhibition of…
Article
In one more initiative of articulation for teaching, Fiocruz shares its capacity and resources with international partners. From March 22nd, 40 students of the Master's in Public Health, from the Faculty of Social Sciences, University Lúrio (Unilúrio), in Mozambique (Africa) will attend the course Scientific Research Methodology - already offered in a transversal way for different Foundation courses. The classes will be taught by professors from the Aggeu Magalhães Institute (Fiocruz Pernambuco), under the leadership of the assistant general coordinator of Education at Fiocruz, Eduarda…
Article
Fiocruz's president, Nísia Trindade Lima, was invited to be a member of the Steering Committee Gender Summit, which had its first meeting on January 26th. The group is composed of high-level representatives from key institutions, responsible for approving and suggesting ideas on the final agenda of the event. The 20th Gender Summit will be hosted by Brazil, in June 2021, virtually. Preparations for the GS20 are guided by the central partnership between CNPq (National Council for Scientific and Technological Development), the British Council in Brazil and Portia (founder of GS). The 20th…
Article
The genomic surveillance in Brazil gains a reinforcement with the new assay for the Sars-CoV-2 strains detection, by means of the RT-PCR protocol, developed by researchers from the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia). The tool was announced by the researcher and vice director of Research and Innovation at Fiocruz Amazônia, Felipe Naveca. The new trial allows screening of the most important strains in circulation in Brazil.
“The tool is an innovative product that was developed in our laboratory. There are other similar protocols, but this one was validated against 87…
Article
The Fiocruz Genomic Network is participating in a project by the Ministry of Health that will sequence new coronavirus samples throughout the national territory. Currently, only three central laboratories (Lacens) in the states are capable of this task. The Network brings together researchers from various institutes of the Foundation to study genetics and genomes of viruses, bacteria, fungi, parasites, and humans, in addition to receiving support from the Network of Technological Platforms (in Portuguese, Rede de Plataformas Tecnológicas), with access to sequencers and bioinformatics.…
Article
On February 5, the Ministry of Health (MoH) and Fiocruz launched a public notice for the construction of the Industrial Complex of Biotechnology in Health (Cibs, in the Portuguese acronym). The document opens a bidding process for hiring investors interested in participating in the construction of a new complex of the Immunobiological Technology Institute of the Oswaldo Cruz Foundation (Bio-Manguinhos/Fiocruz), in Santa Cruz, in Rio de Janeiro.
The Bio-Manguinhos director/Fiocruz, Maurício Zuma, said he was thrilled with the event, remembering that the Institute has reached this moment…
Article
A project of Fiocruz Pernambuco was selected in a public call released by the Federal Government in a partnership with other countries that are part of BRICS - formed by Brazil, Russia, India, China and South Africa. The public notice’s resources had R$6.2 million provided by the Ministry of Science, Technology and Innovation and R$1 million provided byt the Ministry of Health to fund researches directed to facing the Covid-19 pandemic.
Of the 85 proposals received, 12 were selected, of which three are coordinated by researchers of the Oswaldo Cruz Foundation. One of them is from Pernambuco,…
Article
On the side of Maici river (Aldeia Dudu), an indigenous woman called Potai Pirahã received the first dose of the Covid-19 vaccine. Aftere 28 days, she should get the second dose. Potai Pirahã is part of a group of 713 indigenous people that will be vaccinated in the municipality of Humaitá (in the South of Amazonas). The vaccination in indigenous lands of the area started on January 26th, along with lectures to raise awareness about the importance of the Covid-19 vaccination and quick tests provided by Fiocruz Rondônia. A total of 600 tests were done by the campaign on January 26 and 27.…
Article
On January 29th, Fiocruz officially submited the application to register the Covid-19 vaccine to the Healthy Surveillance Agency (Anvisa), which will allow the Oxford-AstraZeneca immunizer Covid-19 vaccine across the country. “This is another key step in facing the pandemic and it will allow the Brazilian population to have broad access to the vaccine, which will be distributed through the Ministry of Health’s National Immunization Program”, celebrates Fiocruz’s president, Nísia Trindade Lima.
The application to the final register is a result of a process that started on June 2020, through…
Article
O município do Rio de Janeiro inicia nesta quarta-feira (27/1), ao meio-dia, uma nova fase de seu Plano de Vacinação. Até o dia 3 de fevereiro, profissionais de saúde com 60 anos ou mais que atuam na cidade nas redes pública e privada, e trabalhadores envolvidos na realização de exames para Covid-19 deverão procurar uma das 236 clínicas da família e centros municipais de saúde para tomar a vacina. Trabalhadores da Fiocruz que se encaixam nesse critério deverão também buscar as clínicas da família para vacinação. Não haverá vacinação desses trabalhadores na Fundação.
Podem ser vacinados nesta…
Article
In a partnership with the Amazonas Foundation for Health Surveillance (FVS-AM), researchers of the Leônidas and Maria Deane Institute (ILMD/Fiocruz Amazon) have confirmed the second case of reinfection by the Sars-CoV-2 in Brazil. The reinfection occurred in manaus, capital of the state of Amazonas, by the new variant identified in the state, designateed B.1.1.28.1 or P.1. The case was confirmed by virologist and researcher Felipe Naveca. Read here the article on the new variant. Read the article on the reinfection case.
“The reinfection was confirmed when we finished the genetic sequencing…
Article
Analyzing the characteristics of patients hospitalized due to Covid-19 in Brazil and examining the impact of the disease in the use of resources and in hospital mortality were the goals of the study that assessed the first 250 thousand hospitalizations due to Covid-19 in Brazil, between February 16 and August 15, 2020. “The work has two great contributions to give: documenting the effect of the epidemic on the Brazilian population and on the country’s health system, and showing the importance of having a fair, inclusive and equitable health system, especially for the most vulnerable…
Article
At the end of the 1st Extraordinary Public Meeting of the Collegiate Board, held on January 17, the Brazilian Health Regulatory Agency (Anvisa) authorized the emergency use of two vaccines against Covid-19: Oxford-AstraZeneca, Fiocruz, and Coronavac, of the Butantan Institute. A historic day for Anvisa and also for Brazil, marking the beginning of vaccination in the country.
The emergency request submitted by Fiocruz refers to the 2 million ready-made vaccines that will be imported from the Serum Institute, one of the centers trained by AstraZeneca to produce the vaccine in India. The…
Article
Com a liberação das exportações comerciais pelo governo indiano, as duas milhões de doses de vacinas prontas, compradas do Instituto Serum, serão embarcadas em Mumbai e têm chegada prevista ao Brasil no dia 22 de janeiro, às 17h40, pelo aeroporto de Guarulhos, em São Paulo. Após os trâmites alfandegários, as vacinas seguirão diretamente para o aeroporto internacional RIO-Galeão, no Rio de janeiro, para desembarque e trajeto até a Fiocruz.
Em obediência às normas regulatórias, as vacinas passarão, no Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos/Fiocruz), por checagem de…
Article
O Brasil deu início, nesta segunda-feira (18/1), à Campanha de Vacinação contra a Covid-19. Por contar com trabalhadores que estão classificados nos grupos prioritários para essa primeira fase de vacinação, a instituição também receberá doses da vacina e iniciará a vacinação de seus trabalhadores nesta quarta-feira (20/1).
O Plano de vacinação da Covid-19 dos trabalhadores da Fiocruz, elaborado pela Coordenação da Pandemia da Presidência, seguirá sempre os critérios de vacinação estabelecidos pelo Programa Nacional de Imunizações (PNI/MS). Neste momento, foram identificados como pertencentes…
Article
A Fiocruz recebeu, nos dias 14, 15 e 16 de janeiro, a visita de uma comitiva da Casa Civil da Presidência da República, que esteve na Fundação para conhecer de perto o trabalho desenvolvido pela instituição em diversas áreas, da produção de vacinas e medicamentos à pesquisa clínica e à atuação nos bancos de leite humano, entre outros campos. O ministro-chefe da Casa Civil, Walter Braga Netto, que esteve pela primeira vez na instituição, participou dos dois primeiros dias da visita e se disse feliz em ver a capacidade da Fiocruz em dar respostas aos problemas de saúde pública. Ele disse que a…
Article
A researcher of the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) confirms the identification of the origin of the new variant of the Sars-CoV-2 in Amazonas. The new variant was provisionally named B.1.1.28 (K417N / E484K / N501Y). Led by Felipe Naveca, the study suggests that the strains, identified in Japanese travelers that had been in the Amazonian region, evolved from a viral strain in Brazil that is spreading around Amazonas.
The results also point out that the mutation detected in the B.1.1.28 (K417N / E484K / N501Y) variant is a recent phenomenon, that probably…
Article
Nísia Trindade Lima was renominated for the position of President of Fiocruz, for the period of 2021-2024. Lima was elected on the first place of the three-name list unanimously homologated by Fiocruz Advisory Board, which was handed to the Health Minister, Eduardo Pazuello, last November. Fiocruz 2020 elections were the most significant in the institution’s history, with the participation of 4,400 voters - 91.6% of the 4,847 employees that are eligible to vote.
The president of the institution has been chosen through an election among its civil servants since 1989, the same way it’s…
Article